NZ545047A - Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery - Google Patents

Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery

Info

Publication number
NZ545047A
NZ545047A NZ545047A NZ54504799A NZ545047A NZ 545047 A NZ545047 A NZ 545047A NZ 545047 A NZ545047 A NZ 545047A NZ 54504799 A NZ54504799 A NZ 54504799A NZ 545047 A NZ545047 A NZ 545047A
Authority
NZ
New Zealand
Prior art keywords
percent
coating composition
weight
acid
chitosan
Prior art date
Application number
NZ545047A
Other languages
English (en)
Inventor
H Hammond
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NZ545047A publication Critical patent/NZ545047A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0083Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Paints Or Removers (AREA)
NZ545047A 1998-02-11 1999-02-09 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery NZ545047A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2177398A 1998-02-11 1998-02-11

Publications (1)

Publication Number Publication Date
NZ545047A true NZ545047A (en) 2009-05-31

Family

ID=21806073

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ545047A NZ545047A (en) 1998-02-11 1999-02-09 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery

Country Status (11)

Country Link
EP (2) EP1695719A1 (https=)
JP (1) JP2002502885A (https=)
KR (1) KR20010015915A (https=)
CN (2) CN101186928A (https=)
AU (1) AU2663799A (https=)
CA (1) CA2320302A1 (https=)
EA (1) EA019099B1 (https=)
IL (1) IL137765A0 (https=)
NZ (1) NZ545047A (https=)
WO (1) WO1999040945A2 (https=)
ZA (1) ZA991102B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034208A1 (en) * 1999-11-05 2001-05-17 The Regents Of The University Of California Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
US6752987B1 (en) 1995-02-28 2004-06-22 The Regents Of The University Of California Adenovirus encoding human adenylylcyclase (AC) VI
WO2000024415A2 (en) 1998-10-28 2000-05-04 Cornell Research Foundation, Inc. Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
EP1255822A2 (en) 1999-12-27 2002-11-13 The Regents Of The University Of California Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure
WO2002002148A2 (en) * 2000-06-30 2002-01-10 Collateral Therapeutics, Inc. Dual recombinant gene therapy compositions and methods of use
JP2005052001A (ja) * 2001-07-05 2005-03-03 Takara Bio Inc 遺伝子治療剤
DE602006017071D1 (de) 2005-01-25 2010-11-04 Five Prime Therapeutics Inc Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
GB2437893A (en) * 2006-07-25 2007-11-07 Celladon Corp Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy
US8157760B2 (en) 2007-07-18 2012-04-17 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
WO2009105135A1 (en) 2008-02-19 2009-08-27 Celladon Corporation Compositions for enhanced uptake of viral vectors in the myocardium
US20130096500A1 (en) * 2011-07-07 2013-04-18 Gabor Rubanyi Nucleic acid based cardiovascular therapeutics
US20140296769A1 (en) * 2013-03-28 2014-10-02 Silk Road Medical, Inc. Methods and Systems for Establishing Retrograde Carotid Arterial Blood Flow
WO2019089385A1 (en) 2017-11-02 2019-05-09 Silk Road Medical, Inc. Fenestrated sheath for embolic protection during transcarotid carotid artery revascularization

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA001616B1 (ru) * 1995-02-28 2001-06-25 Зе Риджентс Оф Зи Юнивесити Оф Кэлифоньэ Способ лечения болезни сердца, способ лечения недостаточности периферических сосудов и способ ограничения доставки и экспрессии трансгенной конструкции в определенном органе или структуре
US5869230A (en) * 1995-03-30 1999-02-09 Beth Israel Hospital Association Gene transfer into the kidney
WO1999017807A1 (en) * 1997-10-08 1999-04-15 Cobra Therapeutics Ltd. Use of a vasoactive compound in the enhancement of gene delivery
US6376471B1 (en) * 1997-10-10 2002-04-23 Johns Hopkins University Gene delivery compositions and methods

Also Published As

Publication number Publication date
CN1301181A (zh) 2001-06-27
ZA991102B (en) 2000-03-31
JP2002502885A (ja) 2002-01-29
EA200000828A1 (ru) 2001-02-26
WO1999040945A3 (en) 1999-09-30
AU2663799A (en) 1999-08-30
CN101186928A (zh) 2008-05-28
EP1695719A1 (en) 2006-08-30
CN100350979C (zh) 2007-11-28
IL137765A0 (en) 2001-10-31
KR20010015915A (ko) 2001-02-26
EA019099B1 (ru) 2014-01-30
WO1999040945A2 (en) 1999-08-19
CA2320302A1 (en) 1999-08-19
EP1053025A2 (en) 2000-11-22

Similar Documents

Publication Publication Date Title
EP1793684B1 (en) Process for preserving fresh produce and coating composition therefor
US6165529A (en) Process for preventing fresh produce and coating composition therefor
US5376391A (en) Method of increasing the stability of fruits, vegetables or fungi and composition thereof
RU2112384C1 (ru) Способ консервирования растительного сырья
US7981454B2 (en) Process and coating composition for extending the shelf life of post harvest produce
CA2295243C (en) Process for preserving fresh produce and coating composition therefor
US6299915B1 (en) Protective coating for food, method for producing same and products coated by same
NZ545047A (en) Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
CN109105470A (zh) 一种蔬菜保鲜工艺
US6203833B1 (en) Process for preserving fresh produce
Alandes et al. Improving the quality of fresh‐cut apples, pears, and melons using natural additives
US20250000112A1 (en) Edible coating for preventing the food spoilage
JPH01304844A (ja) 野菜・果実の鮮度保持剤組成物
OA21582A (en) Edible coating for preventing the food spoilage.
JPH02207740A (ja) 野菜・果実の鮮度保持剤組成物
JP2000139340A (ja) 青果物の病害防止剤
JP2002034527A (ja) 生鮮食品の変敗抑制機能を有しかつ容器・梱包等の軽量化ならびに流通コスト削減を推進する可食コーティング製剤
JPH09252719A (ja) カット野菜・カット果物の鮮度保持剤
JPH01304845A (ja) 野菜・果実の鮮度保持剤組成物

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired